Piramal Pharma Limited functions as a pharmaceutical company, offering a range of pharmaceutical products and services such as injection and HPAPI. Established in 2020, the company is headquartered in Mumbai, India, and operates as a subsidiary of Piramal Enterprises Limited.
Navigation section
Piramal Pharma Limited
- 271.20 25.75(10.49%) 268.55 22.95(9.34%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 247.00 246.30 | 275.00 275.00 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 114.35 (15-Mar-2024) 114.45 (15-Mar-2024) | 307.90 (06-Nov-2024) 307.85 (06-Nov-2024) |
- Open
- 247.65 249.65
- Previous Close
- 245.45 245.60
- Volume
- 247.94
- Total Traded value
- 653.15 (₹ Lakhs)
- Upper circuit
- 294.50 172.10
- Lower circuit
- 196.40 114.80
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 113,598 | 0 |
| Bid Price | Quantity |
|---|---|
| 268.75 | 113,598.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 113,598 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹359.54 Cr |
| PE Ratio (TTM): | 50.66 |
| PB Ratio: | 4.64 |
| Industry P/E: | 0.00 |
| Debt to Equity: | 0.003 |
| ROE: | 9.16 |
| EPS (TTM): | 4.85 |
| Book Value: | 4,325.25 |
| Face Value: | 10.00 |
Financials
| Sep, 2022 | Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | |
|---|---|---|---|---|---|
| Revenue | 828.87 Cr | 994.24 Cr | 846.43 Cr | 1,054.58 Cr | 813.29 Cr |
| Profit | 47.33 Cr | 77.16 Cr | -33.36 Cr | 41.70 Cr | -2.42 Cr |
| Expense | 857.71 Cr | 987.13 Cr | 914.01 Cr | 1,051.82 Cr | 866.43 Cr |
| Comprehensive income | 40.57 Cr | 72.20 Cr | -32.60 Cr | 68.59 Cr | 9.82 Cr |
| EPS | 0.40 | 0.61 | -0.28 | 0.35 | -0.02 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Piramal Pharma Limited | Oct, 2022 Oct, 2022 | Pharmaceuticals Pharmaceuticals | PPLPHARMA PPLPHARMA |
Shareholding pattern
Sep, 2023 Sep, 2023 Aug, 2023 Jun, 2023 Mar, 2023
Piramal Pharma Limited FAQ's
What is the range of today's stock performance for Piramal Pharma Limited?
Today's stock performance witnessed a fluctuation from a minimum of 247.00 on the NSE (National Stock Exchange) to a maximum of 275.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 246.30 to a high of 275.00.
What are the 52-week low and high values for Piramal Pharma Limited?
The stock's performance over the past 52 weeks reveals a low of 114.35 (occurred on 15-Mar-2024) and a high of 307.90 (achieved on 06-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 114.45 (on 15-Mar-2024), and the 52-week high is 307.85 (on 06-Nov-2024).
What was the opening and previous closing prices for Piramal Pharma Limited?
The stock's performance over the past 52 weeks reveals a low of 114.35 (occurred on 15-Mar-2024) and a high of 307.90 (achieved on 06-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 114.45 (on 15-Mar-2024), and the 52-week high is 307.85 (on 06-Nov-2024).
What is the total volume and traded value for Piramal Pharma Limited for the day?
The total volume is 248, and the total traded value is 653.15 (₹ Lakhs).
What are the upper and lower circuit limits for Piramal Pharma Limited?
The upper circuit limit is 294.50, and the lower circuit limit is 196.40.
What is the market cap and PE ratio for Piramal Pharma Limited?
The market cap is ₹359.54 Cr, and the PE ratio (TTM) is 0.00.
What is the PB ratio, industry P/E, and debt to equity ratio for Piramal Pharma Limited?
The PB ratio is 0.06, industry P/E is 0.00 , and the debt to equity ratio is 0.003.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Piramal Pharma Limited?
ROE is 9.16, EPS is 4.85, book value is 4,325.25
What are the revenue and profit figures for the latest quarter and previous quarters for Piramal Pharma Limited?
In Sep 2022, Revenue is ₹8288700000, and Profit is ₹473300000. In Sep 2023, Revenue is ₹9942400000.00, and Profit is ₹771600000.00.
When was Piramal Pharma Limited listed, and what industry does it belong to?
The company, Piramal Pharma Limited, was listed in Oct 2022 and belongs to the Pharmaceuticals industry. Its NSE symbol is PPLPHARMA.
What is the current shareholding pattern of the Piramal Pharma Limited?
As of latest available update, promoters hold 35.02%, the public holds 64.60%, and Employee Trusts holds 0.38.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 25
- Threads
- 81
